Back to Search Start Over

Latin American and Caribbean consensus on noninvasive central nervous system neuromodulation for chronic pain management (LAC2-NIN-CP)

Authors :
Durval Campos Kraychete
Fabian Piedimonte
Kátia Monte-Silva
Manuel Sempértegui Gallegos
Elias Atencio
Jean Pascal Lefaucheur
João Batista Santos Garcia
Lucy S. Chipchase
Patricia Bonilla
Luis C. L. Correia
Katia Nunes Sá
Aziza Jreige Iskandar
Valquíria Aparecida da Silva
Abrahão Fontes Baptista
Fuad Ahmed Hazime
María Del Rosario Berenguel Cook
Ricardo Galhardoni
José Alberto Flores Cantisani
Marco Antonio Marcolin
Ana Mércia Fernandes
Andre R. Brunoni
Alexandre Hideki Okano
Manoel Jacobsen Teixeira
Frantz Colimon
John Jairo Hernández-Castro
Daniel Ciampi de Andrade
Wolnei Caumo
William Delgado Barrera
César Amescua-García
Didier Bouhassira
Argelia Lara-Solares
Pedro Schestatsky
María Antonieta Ricco
Egas M. Caparelli-Dáquer
Carlos Guerrero
Source :
Pain Reports, PAIN Reports, Vol 4, Iss 1, p e692 (2019)
Publication Year :
2019
Publisher :
Wolters Kluwer, 2019.

Abstract

Supplemental Digital Content is Available in the Text.<br />Introduction: Chronic pain (CP) is highly prevalent and generally undertreated health condition. Noninvasive brain stimulation may contribute to decrease pain intensity and influence other aspects related to CP. Objective: To provide consensus-based recommendations for the use of noninvasive brain stimulation in clinical practice. Methods: Systematic review of the literature searching for randomized clinical trials followed by consensus panel. Recommendations also involved a cost-estimation study. Results: The systematic review wielded 24 transcranial direct current stimulation (tDCS) and 22 repetitive transcranial magnetic stimulation (rTMS) studies. The following recommendations were provided: (1) Level A for anodal tDCS over the primary motor cortex (M1) in fibromyalgia, and level B for peripheral neuropathic pain, abdominal pain, and migraine; bifrontal (F3/F4) tDCS and M1 high-definition (HD)-tDCS for fibromyalgia; Oz/Cz tDCS for migraine and for secondary benefits such as improvement in quality of life, decrease in anxiety, and increase in pressure pain threshold; (2) level A recommendation for high-frequency (HF) rTMS over M1 for fibromyalgia and neuropathic pain, and level B for myofascial or musculoskeletal pain, complex regional pain syndrome, and migraine; (3) level A recommendation against the use of anodal M1 tDCS for low back pain; and (4) level B recommendation against the use of HF rTMS over the left dorsolateral prefrontal cortex in the control of pain. Conclusion: Transcranial DCS and rTMS are recommended techniques to be used in the control of CP conditions, with low to moderate analgesic effects, and no severe adverse events. These recommendations are based on a systematic review of the literature and a consensus made by experts in the field. Readers should use it as part of the resources available to decision-making.

Details

Language :
English
ISSN :
24712531
Volume :
4
Issue :
1
Database :
OpenAIRE
Journal :
Pain Reports
Accession number :
edsair.doi.dedup.....e318a1f964b3edb429bd21b7a1eae11f